CytoMed Therapeutics Limited - Ordinary Shares - Nakit Akışı (NASDAQ:GDTC)

Financials

İşletme faaliyetlerinden elde edilen nakit -1.04 M-2.6 M-1.98 M-2.88 M — Yatırım faaliyetlerinden elde edilen nakit -353.11 K-2.14 M824.58 K722.67 K — Finansman faaliyetlerinden elde edilen nakit 722.71 K8.28 M-47.5 K162.26 K — Serbest nakit akışı -1.04 M-2.6 M-1.98 M-2.88 M —

Haberler

CytoMed hisseleri Malezya’daki klinik deneme ortaklığını duyurduktan sonra yükseldi

CytoMed stock jumps after announcing clinical trial partnership in Malaysia

CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital

CytoMed Therapeutics secures $500,000 investment for subsidiary

CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

CytoMed, lösemi tedavisi için umut verici klinik öncesi sonuçlar açıkladı

CytoMed reports promising preclinical results for leukemia treatment

CytoMed Therapeutics shareholders approve all proposals at annual meeting

CytoMed Therapeutics schedules annual shareholder meeting